ChemicalBook > Product Catalog >API >Antineoplastic agents >Other antineoplastic Drugs >Cediranib

Cediranib

Cediranib Structure
CAS No.
288383-20-0
Chemical Name:
Cediranib
Synonyms
CS-377;AZD2171;Recentin;Cediranib;Cadiranib;NSC-732208;Cediranib R;Cediranib, >=99%;Cediranib (AZD217);Cediranib(AZD2171)
CBNumber:
CB3947063
Molecular Formula:
C25H27FN4O3
Molecular Weight:
450.51
MOL File:
288383-20-0.mol
MSDS File:
SDS
Modify Date:
2023/9/6 17:45:48

Cediranib Properties

Melting point 135-138°C
Boiling point 626.6±55.0 °C(Predicted)
Density 1.285
storage temp. Sealed in dry,Store in freezer, under -20°C
solubility Acetone (Slightly), DMSO (Slightly), Methanol (Slightly)
form Solid
pka 16.14±0.30(Predicted)
color White to Off-White

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
HS Code  2933599590
NFPA 704
0
2 0

Cediranib Chemical Properties,Uses,Production

Description

Receptors for VEGF have central roles in vasculogenesis and angiogenesis and thus serve as targets for cancer therapy. Cediranib is a potent inhibitor of VEGF receptor tyrosine kinases, including VEGFR1, 2, and 3 (IC50s = 5, 1, and 3 nM, respectively). It also potently inhibits a variety of other receptor and non-receptor tyrosine kinases, including several in the platelet-derived growth factor, fibroblast growth factor, and endothelial growth factor receptor families. Cediranib blocks tubule formation by human umbilical vein endothelial cells in vitro and prevents angiogenesis as well as xenograft tumor growth in vivo. Because of these effects, cediranib has potential use in a range of cancers.

Uses

Cediranib (AZD2171) inhibited VEGF-stimulated proliferation and KDR phosphorylation with IC50 of 0.4 and 0.5 nM, respectively.

Cediranib Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 247)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Hebei Mojin Biotechnology Co., Ltd +8613288715578 China 12450 58 Inquiry
Henan Tianfu Chemical Co.,Ltd. +86-0371-55170693 +86-19937530512 China 21668 55 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29894 58 Inquiry
Hebei Guanlang Biotechnology Co., Ltd. +86-19930503282 China 8822 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry

Cediranib Spectrum

Cediranib 4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline Cadiranib (AZD2171) Cediranib(AZD2171) AZD2171 Recentin Cadiranib Cediranib R 4-((4-fluoro-2-Methyl-1H-indol-5-yl)oxy)-6-Methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline Cediranib (AZD217) Cediranib dihydrochloride NSC-732208 4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline Cediranib (AZD2171) Cediranib 4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline Cediranib, >=99% (557795-03-6) cediranib RECENTIN;AZD2171;AZD 2171;AZD-2171 CS-377 Quinazoline, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]- Cediranib (free base) Cediranib USP/EP/BP Cediranib (NSC-732208 288383-20-0 Cediranib AZD2171, Cediranib AZD2171|||NSC-732208 Carprofen Impurity 8(Carprofen EP Impurity H ) 288383-20-0 C25H27FN4O3 Inhibitors Antineoplastic APIs 288383-20-0